Literature DB >> 16766610

Amyloid fibrils of glucagon characterized by high-resolution atomic force microscopy.

Kathy L De Jong1, Bev Incledon, Christopher M Yip, Michael R DeFelippis.   

Abstract

Glucagon solutions at pH 2.0 were subjected to mechanical agitation at 37 degrees C in the presence of a hydrophobic surface to explore the details of aggregation and fiber formation. High-resolution intermittent-contact atomic force microscopy performed in solution revealed the presence of aggregates after 0.5 h; however, longer agitation times resulted in the formation of fibrillated structures with varying levels of higher-order assembly. Height, periodicity, and amplitude measurements of these structures allowed the identification of four distinct fiber types. The most elementary fiber form, designated a filament, self-associates in a specific wound fashion to produce protofibrils composed of two filaments. Subsequent self-assembly of these filaments and protofibrils leads to two well-defined fibrillar motifs, termed Type I and Type II. Atomic force microscopy imaging of pH 2.8 glucagon solutions not agitated or exposed to elevated temperature revealed the presence of amorphous aggregates before the formation of fibrillar structures similar to those seen at pH 2.0. Time-course solution Fourier transform infrared spectroscopy and thioflavin T binding studies suggested that glucagon aggregation and fibril formation were associated with the development of beta-sheet structure. The results of these studies are used to describe a possible mechanism for glucagon aggregation and fibrillation that is consistent with a hierarchical assembly model proposed for amyloid fibril formation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16766610      PMCID: PMC1544305          DOI: 10.1529/biophysj.105.077438

Source DB:  PubMed          Journal:  Biophys J        ISSN: 0006-3495            Impact factor:   4.033


  46 in total

1.  A general model for amyloid fibril assembly based on morphological studies using atomic force microscopy.

Authors:  Ritu Khurana; Cristian Ionescu-Zanetti; Maighdlin Pope; Jie Li; Liza Nielson; Marina Ramírez-Alvarado; Lynn Regan; Anthony L Fink; Sue A Carter
Journal:  Biophys J       Date:  2003-08       Impact factor: 4.033

2.  Atomic force microscope.

Authors: 
Journal:  Phys Rev Lett       Date:  1986-03-03       Impact factor: 9.161

3.  Probing the mechanism of insulin fibril formation with insulin mutants.

Authors:  L Nielsen; S Frokjaer; J Brange; V N Uversky; A L Fink
Journal:  Biochemistry       Date:  2001-07-27       Impact factor: 3.162

4.  Amyloidogenic self-assembly of insulin aggregates probed by high resolution atomic force microscopy.

Authors:  Ralf Jansen; Wojciech Dzwolak; Roland Winter
Journal:  Biophys J       Date:  2004-12-01       Impact factor: 4.033

5.  The changing face of glucagon fibrillation: structural polymorphism and conformational imprinting.

Authors:  Jesper Søndergaard Pedersen; Dantcho Dikov; James L Flink; Hans Aage Hjuler; Gunna Christiansen; Daniel Erik Otzen
Journal:  J Mol Biol       Date:  2005-11-09       Impact factor: 5.469

6.  Rational design of aggregation-resistant bioactive peptides: reengineering human calcitonin.

Authors:  Susan B Fowler; Stephen Poon; Roman Muff; Fabrizio Chiti; Christopher M Dobson; Jesús Zurdo
Journal:  Proc Natl Acad Sci U S A       Date:  2005-07-08       Impact factor: 11.205

7.  Watching amyloid fibrils grow by time-lapse atomic force microscopy.

Authors:  C Goldsbury; J Kistler; U Aebi; T Arvinte; G J Cooper
Journal:  J Mol Biol       Date:  1999-01-08       Impact factor: 5.469

8.  Common core structure of amyloid fibrils by synchrotron X-ray diffraction.

Authors:  M Sunde; L C Serpell; M Bartlam; P E Fraser; M B Pepys; C C Blake
Journal:  J Mol Biol       Date:  1997-10-31       Impact factor: 5.469

9.  Formation and structure of gels and fibrils from glucagon.

Authors:  G H Beaven; W B Gratzer; H G Davies
Journal:  Eur J Biochem       Date:  1969-11

Review 10.  Toward understanding insulin fibrillation.

Authors:  J Brange; L Andersen; E D Laursen; G Meyn; E Rasmussen
Journal:  J Pharm Sci       Date:  1997-05       Impact factor: 3.534

View more
  12 in total

1.  Quartz crystal microbalance studies of multilayer glucagon fibrillation at the solid-liquid interface.

Authors:  Mads Bruun Hovgaard; Mingdong Dong; Daniel Erik Otzen; Flemming Besenbacher
Journal:  Biophys J       Date:  2007-05-18       Impact factor: 4.033

2.  Early stages of amyloid fibril formation studied by liquid-state NMR: the peptide hormone glucagon.

Authors:  Anna Sigrid Pii Svane; Kasper Jahn; Taru Deva; Anders Malmendal; Daniel Erik Otzen; Jens Dittmer; Niels Chr Nielsen
Journal:  Biophys J       Date:  2008-03-13       Impact factor: 4.033

3.  Concentration dependence of alpha-synuclein fibril length assessed by quantitative atomic force microscopy and statistical-mechanical theory.

Authors:  Martijn E van Raaij; Jeroen van Gestel; Ine M J Segers-Nolten; Simon W de Leeuw; Vinod Subramaniam
Journal:  Biophys J       Date:  2008-08-01       Impact factor: 4.033

4.  Molecular assembly of thyroglobulin induced by in vitro nitric oxide treatments: implication its role in thyroid cells.

Authors:  Dong-Ju You; Gil-Ja Jhon; Hyun Suk Jung
Journal:  Protein J       Date:  2013-12       Impact factor: 2.371

Review 5.  Factors affecting the physical stability (aggregation) of peptide therapeutics.

Authors:  Karolina L Zapadka; Frederik J Becher; A L Gomes Dos Santos; Sophie E Jackson
Journal:  Interface Focus       Date:  2017-10-20       Impact factor: 3.906

6.  Structural transitions and interactions in the early stages of human glucagon amyloid fibrillation.

Authors:  Balakrishnan S Moorthy; Hamed Tabatabaei Ghomi; Markus A Lill; Elizabeth M Topp
Journal:  Biophys J       Date:  2015-02-17       Impact factor: 4.033

7.  Branching in amyloid fibril growth.

Authors:  Christian Beyschau Andersen; Hisashi Yagi; Mauro Manno; Vincenzo Martorana; Tadato Ban; Gunna Christiansen; Daniel Erik Otzen; Yuji Goto; Christian Rischel
Journal:  Biophys J       Date:  2009-02-18       Impact factor: 4.033

8.  Novel use of glucagon in a closed-loop system for prevention of hypoglycemia in type 1 diabetes.

Authors:  Jessica R Castle; Julia M Engle; Joseph El Youssef; Ryan G Massoud; Kevin C J Yuen; Ryland Kagan; W Kenneth Ward
Journal:  Diabetes Care       Date:  2010-03-23       Impact factor: 17.152

9.  Cytotoxic helix-rich oligomer formation by melittin and pancreatic polypeptide.

Authors:  Pradeep K Singh; Dhiman Ghosh; Debanjan Tewari; Ganesh M Mohite; Edmund Carvalho; Narendra Nath Jha; Reeba S Jacob; Shruti Sahay; Rinti Banerjee; Amal K Bera; Samir K Maji
Journal:  PLoS One       Date:  2015-03-24       Impact factor: 3.240

10.  Characterization of seed nuclei in glucagon aggregation using light scattering methods and field-flow fractionation.

Authors:  Cindy C Hoppe; Lida T Nguyen; Lee E Kirsch; John M Wiencek
Journal:  J Biol Eng       Date:  2008-07-09       Impact factor: 4.355

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.